PPM Freezes Prices in 2026 to Support Access to Khmer Medicines

PPM Laboratories, the Kingdom's leading pharmaceutical producer, has announced that there will be no price increases on any of its products in 2026, despite rising costs for certain imported raw materials. In a press release issued on December 8, 2025, by its sales department, the company stated its intention to promote domestic products and support the purchasing power of Cambodian patients in what it considers a challenging economic climate.

PPM is committed to maintaining the same price list for all orders placed in 2026, while continuing to comply with international standards and improve its supply chain. The company presents this decision as an act of loyalty to the Khmer economy: prioritizing "modern Khmer medicines," it explains, means supporting not only its own health and that of its family, but also local businesses and the national economy as a whole. PPM also expresses its gratitude to pharmacies, clinics, hospitals and all consumers who have supported Cambodian-made products for years, calling on them to continue to strengthen, through their purchases, the value and reputation of Khmer products on the domestic market.